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Chapter
G-Protein Coupled  
Hormone Receptors of the  
Hypothalamic-Pituitary-Gonadal 
Axis are Targets of Endocrine 
Disrupting Chemicals
Valentine Suteau, Patrice Rodien and Mathilde Munier
Abstract
Endocrine-disrupting chemicals have received significant concern, since they 
ubiquitously persist in the environment and are able to induce adverse effects 
on health, and more particularly on reproductive function. Most of the stud-
ies focused on nuclear hormone receptors as mediators of sex steroid hormones 
signaling. However, there are increasing evidences that peptides hormones of the 
Hypothalamo-Pituitary-Gonadal axis are targets of endocrine-disrupting chemicals 
(as Gonadotropin-Releasing Hormone, Follicle-Stimulating Hormone, Luteinizing 
Hormone…). The majority of these hormones act on G protein-coupled membrane 
receptors. This review summarizes the effects of endocrine-disrupting chemicals on 
homeostasis of peptides hormone of Hypothalamo-Pituitary-Gonadal axis and on 
their G protein-coupled membrane receptors signaling revealed by experimental, 
clinical, and epidemiological studies in human.
Keywords: G-protein coupled hormone receptors, hypothalamic-pituitary-gonadal 
axis, hormones, endocrine-disrupting chemicals
1. Introduction
Public concern of endocrine-disrupting chemicals (EDCs) has been rising since 
the 1990s. EDCs are defined as “an exogenous substance or mixture that alters 
function(s) of the endocrine system and consequently causes adverse health effects 
in an intact organism, or its progeny, or (sub)populations” [1–3]. EDCs are found 
in many products comprising plasticizers, personal care products, pesticides… [1]. 
Humans are constantly exposed to several different EDCs by ingestion, inhalation, 
and dermal contact. Some classes of EDCs have been studied in detail. Here, we 
selected three classes of EDCs based on knowledge of their effects on Hypothalamo-
Pituitary-Gonadal (HPG) axis: bisphenol A (BPA), phthalates and dichlorodiphe-
nyltrichloroethane (DDT). BPA is one of the most massively produced EDC with 
over three million tons manufactured annually [4]. It is used in food packaging, 
toys, resins used in canned, and medical equipment. Because its incomplete 
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polymerization and its release from polycarbonate at high temperature, exposure to 
BPA is important via food containers [5–7]. Phthalates are used as liquid plasticizers 
found in a wide range of products including plastics, coatings, toys, cosmetics, and 
medical tubing. They are classified in two groups: high molecular weight phthalates, 
such as diethylhexyl phthalte (DEHP), and low molecular weight phthalates, such 
as dibutyl phthalates (DBP) [8]. DDT, an organochlorine pesticide, was largely used 
after the Second World War for its insecticidal properties. Although it was banned 
in the 1970s in the Western World, it continues to be used in developing countries. 
DDT is a synthetic mixture of three isoforms: p,p’DDT, o,p’DDT and p,p’DDD. 
EDCs are originally thought to act through nuclear hormone receptors, such as 
estrogen receptor (ER) or androgen receptor (AR) [9]. During the last decade, we, 
and others, were interested in the effect of EDCs on G-protein-coupled hormone 
receptors (GPCRs). These studies have shown that there are chemical compounds 
in the environment capable of binding to GPCRs and disrupting the activity and 
intracellular signaling pathways of receptor. Moreover, EDCs may alter pathways 
involved in hormone biosynthesis and/or receptor signaling regulation. This review 
summarizes the effects of three classes of EDCs on hormones homeostasis and 
GPCRs signaling involved in the HPG axis. Several molecular mechanisms can be 
involved in the EDC effects on the HPG axis. All studies cited here were performed 
in human species.
2. GPCRs implicated in the HPG axis
The GPCRs are the largest family of cell-surface receptors with over 800 
members accounting for 4% of the encoded human genome [10]. About half of 
them have sensory functions, mediating olfaction, taste, light perception, and 
pheromone signaling. The other half (~350–400) are called endo-receptors, i.e. 
receptors that interact with endogenous ligands [11]. These receptors are involved 
in the detection of many extracellular stimuli (from photons or ions to large hor-
mones proteins). Thus, they have important roles in various physiological systems. 
Dysfunction of GPCRs contributes to many human diseases and GPCRs represent 
34% of all Food and Drug Administration-approved drugs [12].
GPCRs are characterized by a common structure with seven transmembrane 
helices with an extracellular N terminus and an intracellular C terminus [13]. The 
N-terminal portion, or transmembrane domain, constitute the ligand binding site 
while the C-terminal portion and the intracellular loops form a coupling domain 
with the intracellular effectors [14].
In the classical GPCR signaling pathway, after ligand binding, activated-GPCR 
binds the intracellular heterotrimeric G proteins, promoting the release of GDP 
from the Gα subunit, exchanged for GTP and the dissociation of the GTP-bound α 
subunit from βγ dimers. The activated G proteins can then transduce and amplify 
GPCR signals via second messengers to produce a variety of cell responses [15]. 
Briefly, Gαs activates adenylyl cyclases to catalyze the conversion of ATP to cAMP. 
Members of the Gαi family primarily inhibit cAMP production. The Gαq/11 fam-
ily converts phosphatidylinositol 4,5-bisphosphate to diacylglycerol and inositol 
1,4,5-trisphosphate to activate Protein Kinase C and increases intracellular Ca2+ 
levels. Approximately 10% of GPCRs can be coupled with different types of Gs 
subunit depending on cell type and context [16]. The second messengers then target 
other enzymes such as cAMP-dependent protein kinase A (PKA), GMP-dependent 
protein kinase G (PKG), Ca2+-dependent protein kinase C (PKC) or calcium-
sensitive enzymes. The Gβγ subunit can also activate a multitude of effectors 
(GRKs, ion channels, PI3K, phospholipases, MAP kinases) to induce a variety of 
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cellular effects [17]. G protein-mediated signaling is discontinued when the Gα 
subunit hydrolyzes GTP to GDP, due to its intrinsic GTPase activity. This then 
leads to the reassociation of Gα with Gβγ to form the inactive heterotrimer [14]. In 
addition to canonical signaling through heterotrimeric G proteins, some of GPCRs 
can use alternative modes of GPCR activation and initiate G protein–independent 
pathway. The main independent pathway involves a coupling with β-arrestin. 
Originally, β-arrestin was identified as an essential factor in the endocytosis and 
arrest of GPCR signaling induced by heterotrimeric G proteins. Today, other 
functions associated with β-arrestins are being studied and coupling to β-arrestins 
is increasingly described as “scaffolding” proteins involved in multiple G protein-
independent signaling pathways. Indeed, in addition to clathrin, β-arrestins are 
able to bind to many proteins involved in different signaling pathways (Src, ERK1/2 
and JNK3 kinases protein phosphatases, ubiquitin ligases…) [18]. The activation of 
β-arrestins signaling pathways can take place at the membrane but also in intracel-
lular after internalization [15]. Indeed, a growing amount of evidence suggests that 
several molecules have not been known to be regulated by G proteins, suggesting 
that β-arrestin-mediated signaling pathways may be functioning in parallel with 
G-protein-mediated pathways enhancing GPCR signaling pathways.
The Hypothalamo-Pituitary-Gonadal axis is active in the midgestational fetus 
and after birth at the minipuberty but is mainly reactivate at onset of puberty. Some 
receptors of the HPG axis belong to the subfamily of GPCR: gonadotropin-releasing 
hormone receptor (GnRHR), GPR54/Kisspeptin receptor, Neurokinin B receptor 
(NK3R), Prokineticin receptor (PROKR2), follicle stimulating hormone receptor 
(FSHR), human chorionic gonadotropin/luteinizing hormone receptor (hCG/LHR) 
and Relaxin Family Peptide Receptor 2 (RXFP2).
The GnRH, a neuropeptidic hormone, is secreted by hypothalamic GnRH-
expressing neurons into the portal blood vessels in rhythmic pulses [19]. It binds to 
a membrane receptor, the GnRH receptor, also known as the luteinizing hormone 
releasing hormone receptor (LHRHR), on pituitary gonadotropic cells and stimu-
lates the biosynthesis and secretion of LH and FSH [19]. GnRHR is predominantly 
coupled to the Gq-protein [20]. GnRH/GnRHR pathway constitutes the initial step 
in the HPG axis and controls reproduction in both sexes. GnRH loss-of-function 
mutations are associated to normosmic hypogonadotropic hypogonadism [21]. 
GnRH neurons appear to be directly regulated by Kisspeptin-1 (KISS1), with 
Neurokinin B (NKB) and Prokineticin 2 (PROK2). KISS1 is a peptidic hormone 
mostly expressed in the hypothalamus [22]. It activates GPR54/KISS1R, which 
results in the activation of phospholipase C via Gq [12]. GPR54 has been described 
in brain regions, including hypothalamus, but also in peripheral regions [22]. 
Kisspeptin/GPR54 pathway has a crucial role in the onset of puberty, the regula-
tion of sex hormone mediated secretion of FSH/LH, and in the control of fertility 
[22, 23]. Inactivating and activating mutations in KISS1 or GPR54 genes have 
been associated with hypogonadotropic hypogonadism and precocious puberty, 
 respectively [23].
Gonadal function is under pituitary control via the gonadotropin hormones: 
follicle stimulating hormone (FSH) and luteinizing hormone (LH) [24]. FSH and 
LH are synthesized and secreted by the pituitary gonadotropic cells and work 
together in the reproductive system. The human chorionic gonadotropin (hCG) is 
secreted by the placenta and controls ovarian function during gestation. LH and 
hCG share the same GPCR, the hCG/LHR. The FSH and hCG/LH receptor belong 
to the glycoprotein-hormone receptor family. Activation of the LH and FSH recep-
tor results in the production of intracellular cyclic AMP (cAMP) via Gαs proteins 
[25, 26]. However, FSHR and LHR can also couple to several other effectors such as 
Gαq and β-arrestin [26–28]. FSHR is expressed in Sertoli and granulosa cells in male 
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and female gonads, respectively, and is required for normal spermatogenesis and 
growth and maturation of ovarian follicles, as well as for estrogen production [29]. 
In women, LHR induces luteinization of granulosa cells, progesterone synthesis 
and corpus luteum maintenance during the luteal phase [30]. In men, LH stimulates 
testosterone production by Leydig cells [30].
Steroid hormones (estrogen, progesterone, and testosterone) secreted by the 
gonads, bind, and activate nuclear receptors. However, a membrane associated 
estrogen receptor (GPER) has been identified 15 years ago [31, 32]. Activation of 
GPER induces intracellular calcium mobilization, cAMP production and phos-
phorylation cascade involving ERK1/2, PKA, PI3K [33]. This receptor is implicated 
in many physiological functions: uterine proliferation, metabolism, cardiovascular, 
immune, and neural system.
More recently, the INSL3/RXFP2 system pathway was identified for its role in 
reproduction. Insulin-like peptide-3 (INSL3) belongs to the insulin/relaxin family 
of peptidic hormones [34, 35]. This hormone is mainly produced by testicular 
Leydig cells and the production is dependent on the state of Leydig cell differ-
entiation [34]. INSL3 is considered as a marker for Leydig cells function. Its best 
characterized role is in the control of testicular descent since INSL3 gene inacti-
vation males have bilateral cryptorchidism with testis remaining in abdominal 
position [36, 37].
3. Effects of EDCs on signaling of HPG axis G-protein coupled receptors
Effects of EDCs on the activity of HPG axis GPCR identified in the literature 
search are summarized in Table 1.
3.1 Hypothalamic hormones receptor
Currently, there are no data on the effects of EDCs on the activity of human 
hypothalamic hormone receptors. However, some studies have been conducted with 
animal models. Exposure to phthalates leads to a modulation of GnRHR expression 
(positive or negative depending on the studies) [50, 51], as well as an increase in its 
expression in rat uterus [52].
3.2 Gonadotropin hormones receptor
EDCs, like phthalates, increase the FSHR expression in human granulosa cells 
[38]. DDT has been shown to disturb the FSH induced-cAMP accumulation [39] 
and aromatase activity in human granulosa cells [40]. Recently, we showed that 
DDT behaves as an FSHR positive allosteric modulator [41]. DDT interacts with the 
receptor in the minor binding pocket in the transmembrane domain. DDT acts on 
the early steps of activation of the FSHR and induces an increase in FSH-stimulated 
cAMP production. Moreover, the binding of DDT enhances the FSHR response 
to hCG. The increased response to FSH in the presence of DDT and the gain of 
sensitivity to hCG may therefore by deleterious. In opposite, BPA is a FSHR negative 
allosteric modulator [41].
As for FSHR, EDCs, like BPA, disturbes the expression of hCG/LHR in human 
endometrial stromal cells [42]. In CHO-K1 cells stably transfected with hCG/LHR, 
DDT reduced the cAMP accumulation induced by hCG [39, 41] and hLH (Munier 
et al., Arch Toxicol, in revision). Moreover, DDT decreases the hCG- and hLH-
promoted β-arrestin 2 recruitment (Munier et al., Arch Toxicol, in revision). DDT 
seems to act as a negative allosteric modulator of the hCG/LHR signaling.
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GPCR EDC Study model Main results
FSHR DBP
[10−7 to 10−4 M]
Human granulosa 
cells
DBP increases FSHR 
expression
[38]
DDT
[10−7 to 10−4 M]
CHO-K1 - hFSHR DDT decreases cAMP 
production stimulated 
by FSH
[39]
DDE
[10−7 to 10−4 M]
Human granulosa 
cells from IVF
DDE potentiates the 
FSH induced aromatase 
activity
[40]
DDT
[10−7 to 10−5 M]
CHO-K1 - hFSHR DDT is an FSHR positive 
allosteric modulator
[41]
BPA
[10−5 M]
CHO-K1 - hFSHR BPA decreases cAMP 
production stimulated 
by FSH
[41]
hCG/
LHR
BPA
[10−6 M]
Human endometrial 
stromal cells
BPA decreases hCG/LHR 
expression
[42]
DDT
[10−7 to 10−5 M]
CHO-K1 - hCG/
LHR
DDT decreases cAMP 
production stimulated by 
hCG/LHR
[41]
RXFP2 DEHP
[10−9 to 10−5 M]
HEK293 - hRXFP2 DEHP increases cAMP 
production stimulated by 
INSL3
[43]
DBP
[10−9 to 10−5 M]
DBP increases cAMP 
production stimulated by 
INSL3
BPA
[10−11 to 10−7 M]
HEK293 - hRXFP2 BPA increased cAMP 
production stimulated by 
INSL3
DEHP + DBP + BPA
[10−10 to 10−6 M]
HEK293 - hRXFP2 DEHP+DBP + BPA 
mixture decreases cAMP 
production stimulated by 
INSL3
GPER BPA
[10−6 M]
Human breast 
cancer cells
BPA increases GPER 
expression
[44]
BPA
[10−12 to 10−9 M]
Human testicular 
seminoma cells
BPA promotes cellular 
proliferation via GPER 
activation
[45]
BPA
[10−9 to 10−5 M]
HEK293 - hGPER BPA is a GPER agonist 
and induces the Gs protein 
pathway
[46]
BPA
[10−9 to 10−5 M]
Human breast and 
lung cancer cells; 
cancer-associated 
fibroblasts
BPA induces ERK1/2 
activation and gene 
expression through 
GPER leading to cellular 
proliferation and 
migration
[47, 48]
BPA
[10−7 to 10−4 M]
Human granulosa 
cells
BPA induces apoptosis via 
GPER activation
[49]
o,p’-DDE
[10−7 to 10−6 M]
Human breast 
cancer cells
o,p’-DDE is a GPER 
agonist and induces the Gs 
protein pathway
[32, 46]
Table 1. 
Experimental studies studying the effect of EDC on HPG axis GPCR signaling.
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3.3 Insl3 receptor, RXFP2
Only one study has very recently focused on the effect if EDCs on receptor 
signaling to INSL3: RXFP2. In a cellular model of HEK293 transiently expressing 
human RXFP2, individually, BPA, DEHP and DBP potentiate the cAMP response 
to INSL3 [43]. Because of their ubiquity, BPA, DEHP and DBP are present in many 
human biological fluids, as the amniotic liquid. Furthermore, everyone is chroni-
cally exposed to mixtures of environmental chemical factors resulting in toxicologi-
cal interactions that cannot be predicted by reprotoxicological studies of single 
molecules. The combination of these three molecules, at concentrations found in 
human amniotic fluid, decreases the basal activity of RXFP2 as well as the response 
to INSL3. The structural similarity between FSHR and RXFP2 suggests that small 
hydrophobic molecules, like phthalates and BPA, could use the same binding sites 
as DDT in FSHR. The binding of one or two compounds to this site could lead to a 
stabilization of the active state of the receptor driving an increase of agonist activity 
[53]. In contrast, the binding of three compounds (DEHP+DBP + BPA) likely leads 
to a steric hindrance that may prevent the conformational changes necessary for the 
activation of RXFP2 and probably stabilize an inactive state. This study shows that 
in addition to individual EDC targets, HPG axis GPCRs can also be targeted by EDC 
cocktails.
3.4 Membrane sexual steroid hormones receptor
The G protein-coupled receptor (GPER/GPR30) is a membrane estrogen recep-
tor [31]. Gene inactivation of GPER in mice did not induce major modifications 
in reproductive function [54]. However, several studies show that this receptor 
has pro-oncogenic effects in hormone-dependent cancers. Although many EDCs 
exhibit low binding affinities to the nuclear ERs and often require relatively high 
concentrations (>1 μM) to affect genomic pathways, several studies have focused on 
non-genomic signaling mediated by GPER [55].
Various DDT derivatives and BPA bind to GPER with a Kd between 1 to 10 μM 
and are competitors of E2 [46]. The binding affinity of EDCs for GPER is higher 
than for the nuclear receptors. Nevertheless, low concentrations of o,p’DDE and 
BPA increased cAMP production by GPER [32, 45, 46]. BPA and phthalate (MEHP) 
also affect proliferation and migration in human cervical cancer cells [56], in 
human seminoma cells [45], human breast cancer cells and cancer-associated fibro-
blasts that lack nuclear ERs [47, 57] as well as the migration and invasion of lung 
cancer cells [48]. BPA modifies these cellular responses by modulating different 
intracellular signaling pathways (ERK1/2 or Akt phosphorylation, gene expression) 
through GPER activation. In opposite, GPER mediates BPA-induced intracellular 
stress generation (ROS production and calcium accumulation) and apoptosis 
(caspase activation and mitochondrial membrane potential decrease) in human 
granulosa cells [49]. Recently, it has also been shown that BPA increases GPER 
gene expression in breast cancer cell lines [44]. Finally, bisphenols AF and B, two 
substitutes of BPA, exert high estrogenic effects via GPER pathway at nanomolar 
concentrations [58, 59].
4. Effects of EDCs on the synthesis and secretion of HPG axis hormones
Effects of EDCs on the synthesis and secretion of HPG axis hormones identified 
in the literature search are summarized in Table 2.
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Study population EDC exposure Matrix/
biomarker
Main results
192 mother–child pairs 
from e-waste recycling 
town and 70 from 
control area
Free BPA in cord 
blood serum
Kiss gene 
expression in 
placenta
Higher BPA 
concentrations 
showed positive 
correlation with Kiss 
gene expression
[60]
73 girls with central 
precocious puberty and 
31 controls
Seven urinary 
phthalate 
metabolites 
concentrations
Serum 
kisspeptin
Positive correlation 
between kisspeptin- 
and mono-n-butyl 
phthalate
[61]
535 men (18–40 yr) 
living or not in pesticides 
contamined area.
Lipid-adjusted 
DDE and DDT 
concentrations
Serum FSH, 
LH, T, E2
Positive association 
between DDT or DDE 
with T
[62]
749 Swedish (fishermen 
and their pregnant wife)
p,p′-DDE serum 
level
Serum FSH, 
LH, T, E2
Positive association 
between DDE and 
FSH or LH
[63]
97 adult men living in 
nothern Thailand
plasma levels 
of DDT and its 
metabolites
Serum FSH, 
LH, T, E2
Negative association 
of E2 level with 
p,p’-DDE and positive 
association with 
o,p’-DDE
[64]
107 males exposed to 
DDT in Italy
Lipid-adjusted 
p,p’-DDE and 
p,p’-DDT serum 
concentration
Serum FSH, 
LH, T, E2
No association with 
serum hormone levels
[65]
604 adults (men and 
women) in Brazil areas 
exposed to pesticides
Serum 
concentrations 
of 19 pesticides 
including 
p,p’-DDT and 
o,p’-DDT
Serum FSH, 
LH, T, E2
In men, o,p’-DDT level 
was associated with 
lower T, in peri- and 
postmenopausal 
women, p,p’-DDT 
showed inverse 
associations with 
LH; No association 
in premenopausal 
women
[66]
234 mothers and their 
sons
Serum o,p’- and 
p,p’-DDT, 
p,p’-DDE from 
mothers during 
pregnancy or at 
delivery and their 
sons at 9 years.
Serum FSH, 
LH and T in 
sons at 12 years
Prenatal maternal 
DDT and DDE levels 
were associated with 
decreases in LH
[67]
45 girls with early breast 
development, 16 girls 
with early puberty, and 
33 girls with no signs of 
puberty
2,4-DDT and 
4,4’-DDE in 
the serum and 
adipose tissue 
samples.
Serum basal 
and stimulated 
LH and FSH 
level
Basal and stimulated 
LH were higher in girls 
with detectable serum 
DDE levels
[68]
308 young men Urinary BPA 
concentrations
Serum LH, 
T, E2
Higher urinary BPA 
concentrations were 
associated with 
increased serum T, E2, 
and LH
[69]
215 healthy young men 
(18–23 yr)
Urinary BPA 
concentrations
Serum FSH, 
LH, T, E2
Positive association 
between urinary BPA 
and LH levels
[70]
Endocrine Disruptors
8
Study population EDC exposure Matrix/
biomarker
Main results
560 men aged 
18–55 years
Urinary BPA 
concentrations
Serum FSH, 
LH, T
BPA was associated 
with increased serum 
levels of LH and FSH 
in male smokers, 
and with decreased 
serum levels of 
total T in men with 
BMI ≥ 25 kg/m2.
[71]
167 men from an 
infertility clinic
Urinary BPA 
concentrations
Serum FSH, 
LH, T, E2
Positive association 
between urinary BPA 
and serum FSH
[72]
244 mothers-child pairs Serum maternal 
total BPA 
concentration 
during second or 
third trimester
Serum FSH, 
LH, T, E2
No association with 
serum hormone levels
[73]
159 women with 
premature ovarian 
insufficiency and 186 
controls
Urinary 
concentrations 
of BPA
Serum FSH, 
LH
No association with 
serum hormone levels
[74]
106 BPA-exposed 
factories and 250 
unexposed female 
workers
Urinary 
concentrations 
of BPA
Serum FSH, 
LH, E2
Inverse association 
between BPA and FSH 
in unexposed group
[75]
143 healthy, 
premenopausal women
Urinary 
concentrations 
of BPA
Serum FSH, 
LH, E2
No association with 
serum hormone levels
[76]
172 peripubertal boys Urinary 
concentrations 
of BPA
Serum FSH, 
LH, T
No association with 
serum hormone levels
[77]
130 children with 
Attention-Deficit/
Hyperactivity Disorder 
and 68 controls (boys 
and girls)
Urine levels of 
phthalates and 
BPA
Serum FSH, 
LH, T, E2
Among boys with 
ADHD, MBzP and 
MEHP levels were 
positively correlated 
with T; among girls, 
MEP was positively 
correlated with LH 
and T
[78]
136 girls (6–9 yr) with 
early puberty and 136 
controls
Urinary BPA 
concentrations
Serum basal 
and stimulated 
LH and FSH 
level, E2
In early puberty 
group, negative 
correlation between 
BPA and peak FSH 
levels
[79]
479 pregnant women 
and their infants (boys 
and girls)
Urinary 12 
phthalate 
metabolites 
concentrations 
at gestational 
week 28
Serum T, LH, 
FSH during 
mini puberty
No association with 
serum hormone levels
[80]
302 Korean children and 
adolescents
Urinary 
and serum 
concentrations 
of DEHP, MEHP, 
DBP, MBP
Serum FSH, 
LH, T, E2
Positive correlations 
between serum DBP or 
MEHP, and E2 and/or 
LH in children.
[81]
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Study population EDC exposure Matrix/
biomarker
Main results
106 males and females 
(11–88 yr)
Urinary phthalate 
metabolites
Serum FSH, 
LH, T, E2
Positive associations 
between MEHP and 
FSH or T, MEOHP and 
FSH, LH or T, negative 
associations between 
MEHHP and LH, FSH 
or T
[82]
88 infertile men Urinary 
and serum 
concentrations 
of 11 phthalate 
metabolites
Serum FSH, 
LH, T
Negative associations 
between FSH and 
MiBP and MCMHP; 
positive association 
between T and 
phthalates metabolites.
[83]
599 infertile men Urinary 
concentrations 
of 8 phthalate 
metabolites
Serum FSH, 
LH, T, E2
Inverse associations 
between T and MiBP, 
FSH and MEHHP, 
positive relationship 
between E2 and MEP, 
%MEHP and FSH 
and LH
[84]
295 adult men Urinary 
concentrations 
of phthalate 
metabolites
Serum FSH, 
LH, T, E2
Negative association 
between MBzP and 
FSH
[85]
881 healthy men Urinary 
concentrations 
of 14 phthalate 
metabolites
Serum FSH, 
LH, T, E2
%MEHP was 
negatively associated 
with T and FSH
[86]
Male with 
cryptorchidism (421), 
hypospadias (109) or 
controls (425)
5cx-MEPP, 
7cx-MMEHP in 
amniotic fluid 
(11–21 weeks)
INSL3, T in 
amniotic fluid
Negative correlations 
between INSL3 and 
cx7-MMeHP and 
5cxMEPP
[87]
1066 Chinese men of 
reproductive age
Urinary 
concentrations 
of 14 phthalate 
metabolites
Serum levels 
of INSL3, FSH, 
LH, T
Negative association 
between INSL3 and 
MEHP; negative 
association between 
MBP and MiBP with T 
and LH
[88]
male partners of 
subfertile (n = 253) and 
fertile (n = 37) couples
11 phthalate 
metabolites in 
urine and semen
Serum levels 
of INSL3, FSH, 
LH, T, E2
Negative association 
between INSL3 and 
some urinary and 
seminal phthalate 
metabolites
[89]
case–control study of 
176 men (fertile and 
infertile)
Urinary 
concentrations 
of 11 phthalate 
metabolites
Serum levels 
of INSL3, FSH, 
LH, T, E2
inverse association 
MMP, MiBP, MEHP, 
MEHP% and T; MBzP 
and MEHP% were 
negatively associated 
with serum INSL3 
level
[90]
102 mother–child pairs Maternal serum 
concentration 
of MEHP 
(23–35 weeks of 
gestation
Cord blood 
INSL3, FSH, 
LH, T, E2 levels
Inverse associations 
between maternal 
MEHP and INSL3 in 
males
[91]
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4.1 Hypothalamus level
4.1.1 Kisspeptin
No data are available on the impact of DDT on Kisspeptin in epidemiological 
studies in humans.
Interestingly, a study led on 262 mother–child pairs from China found a posi-
tive correlation between cord blood levels of BPA and KISS1 mRNA expression in 
placenta tissue [60].
For phthalates, linear regression analysis showed increasing trend for kisspeptin 
secretion with the concentration of urinary phthalates [61].
4.1.2 GnRH
No epidemiological or experimental studies are available on the possible link 
between EDC levels and GnRH concentration in human. This is probably explained 
by the pulsatile nature of its release and the lack of dosage in clinical practice. 
However, many effects of EDC on GnRH were observed in rodents [93].
4.2 Pituitary level
DDT is rapidly metabolized in the body to DDE. Thus, in epidemiological 
studies, DDE is dosed in the blood more often than DDT. In a cohort of men of 
reproductive age, statistically significant positive association was found between 
the serum level of DDE and LH or FSH [63]. However, others studies did not reveal 
any association between DDT and FSH or LH levels in adult men [62, 64, 65]. In 
peri and postmenopausal women, inverse correlation was found between serum 
DDT and LH [66]. Moreover, it has been shown that maternal exposure to DDT or 
DDE, assayed in prenatal serum, induced a reduction of plasma LH in teenage boys, 
not found for FSH [67]. A study also showed that the serum levels of LH (basal level 
and after GnRH stimulation) was significantly higher in girls with detectable serum 
DDE levels than in girls with undetectable DDE [68]. This difference was not found 
for FSH [68].
For BPA, studies found that higher urinary BPA concentration was associated 
with significantly higher concentrations of serum LH in healthy young men, with or 
without association with FSH [69–71]. However, these results were not confirmed in 
others cohorts of fertile men [73]. Conversely, another study found a positive correla-
tion between urinary BPA concentration and FSH level, without change in LH level in 
a cohort of infertile men [72]. In women, no association was found between urinary 
bisphenol A and LH or FSH levels in premenopausal women [74–76]. Moreover, no 
Study population EDC exposure Matrix/
biomarker
Main results
52 boys with 
cryptorchidism and 128 
control boys
Cord blood BPA 
concentration at 
birth
Cord blood 
INSL3 levels
Higher cord blood 
BPA concentrations 
were associated with 
reduced cord blood 
INSL3 levels
[92]
T: testosterone, E2: estradiol.
Table 2. 
Human biomonitoring studies addressing the relationship between EDC and hormones of HPG axis.
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association was found in healthy children for LH and FSH [77, 78]. A modest nega-
tive correlation was found between urinary BPA concentration and peak of GnRH-
stimulated FSH levels in girls with idiopathic central precocious puberty, without 
difference for LH levels [79].
Maternal phthalates exposure (urinary samples collected during second 
trimester) was not associated with serum LH level or FSH in offspring during 
mini-puberty in boys and girls [80]. However, positive correlations were observed 
between different phthalates and serum LH in prepubescent Korean children (for 
serum DBP or MEHP) [81], in girls with attention-deficit/hyperactivity disorder 
(for urinary MEP) [78] and in Chinese population (11–88 years, males and females) 
(for urinary MEHHP levels) [82]. In the same populations, either negative [82, 83] 
or no effects [78, 81] were observed on FSH level. In men, urinary phthalate 
metabolites were positively associated with LH and FSH levels [84] in one study 
while negative association between urinary phthalates concentrations and levels of 
FSH was found in American men (for MBzP) [85] and in Danish men (for MEHP or 
%MiNP) [86] without impact on LH.
Altogether, epidemiological data have linked exposure to EDC and LH and/
or FSH level but evidence were often inconclusive. The inconsistent findings may 
partly be due to differences in the characteristics and sizes of the cohorts and to the 
different EDC exposure levels among studies.
4.3 Gonadal level
4.3.1 Sexual steroid hormones
Many data are already available on the effect of endocrine disruptors on the 
secretion of sex steroids. Recent reviews list all available studies for DDT [93],  
BPA [93, 94] or phthalates [93, 95–97].
4.3.2 INSL3
No data are available on the impact of DDT on INSL3 in humans epidemiological 
studies.
Several studies showed that INSL3 was negatively impacted by putative phthal-
ate metabolites. The Diisononyl phthalate (DiNP) metabolite, cx7-MMeHP, and 
the DEHP metabolite, 5cxMEPP, showed significant negative correlations with 
INSL3 in amniotic fluid for weeks 11–22 [87]. Moreover, serum levels of INSL3 was 
negatively associated with urinary concentration of mono-2-ethylhexyl phthal-
ate (MEHP) and MBzP among large cohorts of chinese men of reproductive age 
[88–90]. In adjusted models, quartiles increases in phthalates metabolites correlated 
with significant decreases in plasma INSL3 levels [88–90]. It has also been shown 
that maternal serum MEHP concentration (from 23–35 weeks of gestation) was 
negatively correlated with INSL3 level in cord blood mainly in boys [91].
There is also an inverse correlation between BPA level and concentration of 
INSL3 [92]. Indeed, in a population of 180 boys born after 34 weeks of gestation 
(52 cryptorchid and 128 control), cord blood levels of free BPA correlated nega-
tively with INSL3 [92]. In this study, cord blood INSL3 level was also significantly 
decreased in the cryptorchid group compared with the control group [92].
Ex vivo studies on human testicular explant were performed, to study more 
precisely the effect of endocrine disruptors on the secretion of INSL3.
No data are available on the impact of DDT on INSL3 in humans experimental 
studies.
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The exposure of fetal testis (8–12 weeks) to BPA at 10−8 M and 10−5 M for 72 h 
[98], significantly depressed the basal INSL3 production compared with control. 
This treatment also reduced INSL3 mRNA level by more than 20% [99]. However, 
BPA did not modify hCG or hLH-stimulated INSL3 production [98]. Conversely, in 
human adult testes, BPA increased significantly INSL3 production by Leydig cells, 
at a low doses (10−9 M) [100]. Interestingly, its analogs, Bisphenol B and Bisphenol 
S also increased INSL3 production at 10−9 and 10−8 M. Moreover, BADGE, another 
bisphenol, dose dependently increased INSL3 after 48 h of exposure. In contrast, 
BPE dose dependently inhibited INSL3 levels [100].
For phthalates, di-(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) 
phthalate (MEHP) exposition on organo-cultured adult human testis did not affect 
Leydig cell INSL3 concentrations [101].
5. Conclusions
Most epidemiological and experimental studies focus on the effect of EDCs 
on the expression and secretion of hormones, as well as on the activity of nuclear 
steroid receptors. However, a few experimental studies have shown that G protein-
coupled membrane receptors of the HPG axis are targets of EDCs as well. It can 
be pointed out that most of the studies analyzing the effects of EDCs on GPCRs of 
HPG axis have been performed with cell culture systems. In vitro models are valu-
able tools because they are easily manipulated. But the comparison of the effects of 
EDCs in wild-type and GPCRs- inactivated animal models could provide additional 
informations on the mode of action of these compounds.
Mechanisms of GPCR disruption by EDCs include: (1) changes in the expres-
sion; (2) interaction with transmembrane domain receptor; (3) modulation of 
intracellular signaling pathways.
The GPCRs of HPG axis, involved in diverse physiological functions, should be 
considered as possible contributors of the adverse effects of EDCs on reproduction. 
How their modulation by EDCs contributes to these deleterious effects should be an 
important field of investigations in the near future.
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